Bacillus Calmette Guerin (BCG) vaccination/revaccination for prevention of Mycobacterium tuberculosis infection in healthcare students entering clinical training: A randomised placebo controlled proof of principle trial (PoP BCG trial)
- Conditions
- InfectiontuberculosisInfection - Studies of infection and infectious agents
- Registration Number
- ACTRN12619001327178
- Lead Sponsor
- niversity of Otago
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 150
1.Medical or nursing students who start their clinical training at Hasan
Sadikin Hospital
2.Tested IGRA negative at screening
3.Tested HIV negative at screening
4.Completed the written informed consent
1.Retraining nursing students (retraining to transform their nursing
qualification into a degree)
2.A positive prior tuberculin skin test (TST) and/or IGRA
3.A history of treatment for TB disease or latent TB infection
4.A history or evidence of TB disease
5.For female students: currently pregnant or lactating/nursing; or positive
urine pregnancy test during screening
6.History of autoimmune disease or immunosuppression or used
immunosuppressive medication
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.